These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 19481284

  • 21. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15).
    Yokoyama H, Sone H, Oishi M, Kawai K, Fukumoto Y, Kobayashi M, Japan Diabetes Clinical Data Management Study Group.
    Nephrol Dial Transplant; 2009 Apr; 24(4):1212-9. PubMed ID: 18984626
    [Abstract] [Full Text] [Related]

  • 22. Silent cerebral infarction is associated with the development and progression of nephropathy in patients with type 2 diabetes.
    Bouchi R, Babazono T, Yoshida N, Nyumura I, Toya K, Hayashi T, Hanai K, Tanaka N, Ishii A, Iwamoto Y.
    Hypertens Res; 2010 Oct; 33(10):1000-3. PubMed ID: 20613763
    [Abstract] [Full Text] [Related]

  • 23. Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease.
    Bleyer AJ, Sedor JR, Freedman BI, O'Brien A, Russell GB, Graley J, Schelling JR.
    Am J Kidney Dis; 2008 Jan; 51(1):29-37. PubMed ID: 18155530
    [Abstract] [Full Text] [Related]

  • 24. Prevalence and severity of anaemia in patients with type 2 diabetic nephropathy and different degrees of chronic renal insufficiency.
    Li Vecchi M, Fuiano G, Francesco M, Mancuso D, Faga T, Sponton A, Provenzano R, Andreucci M, Tozzo C.
    Nephron Clin Pract; 2007 Jan; 105(2):c62-7. PubMed ID: 17135770
    [Abstract] [Full Text] [Related]

  • 25. Does autonomic neuropathy play a role in erythropoietin regulation in non-proteinuric Type 2 diabetic patients?
    Spallone V, Maiello MR, Kurukulasuriya N, Barini A, Lovecchio M, Tartaglione R, Mennuni G, Menzinger G.
    Diabet Med; 2004 Nov; 21(11):1174-80. PubMed ID: 15498082
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Microalbuminuria prevalence study (MAPS) in hypertensive patients with type 2 diabetes in Thailand.
    Buranakitjaroen P, Deerochanawong C, Bunnag P.
    J Med Assoc Thai; 2005 Nov; 88(11):1624-9. PubMed ID: 16471111
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of tests for microalbuminuria screening in patients with diabetes.
    Incerti J, Zelmanovitz T, Camargo JL, Gross JL, de Azevedo MJ.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2402-7. PubMed ID: 16105865
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Prevalence and risk factors of diabetic nephropathy in an urban South Indian population: the Chennai Urban Rural Epidemiology Study (CURES 45).
    Unnikrishnan RI, Rema M, Pradeepa R, Deepa M, Shanthirani CS, Deepa R, Mohan V.
    Diabetes Care; 2007 Aug; 30(8):2019-24. PubMed ID: 17488949
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Urinary type IV collagen levels in diabetes mellitus.
    Sthaneshwar P, Chan SP.
    Malays J Pathol; 2010 Jun; 32(1):43-7. PubMed ID: 20614725
    [Abstract] [Full Text] [Related]

  • 36. Clinical utility of estimated glomerular filtration rates in predicting renal risk in a district diabetes population.
    Baskar V, Venugopal H, Holland MR, Singh BM.
    Diabet Med; 2006 Oct; 23(10):1057-60. PubMed ID: 16978368
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study.
    Soedamah-Muthu SS, Visseren FL, Algra A, van der Graaf Y, SMART Study Group.
    Diabet Med; 2008 Jan; 25(1):51-7. PubMed ID: 18199132
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.